Personalis (PSNL) Competitors $9.45 +0.52 (+5.82%) Closing price 04:00 PM EasternExtended Trading$9.44 0.00 (-0.05%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PSNL vs. HTFL, VCYT, CON, SGRY, GRAL, ADUS, ARDT, LFST, CELC, and PACSShould you be buying Personalis stock or one of its competitors? The main competitors of Personalis include Heartflow (HTFL), Veracyte (VCYT), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), GRAIL (GRAL), Addus HomeCare (ADUS), Ardent Health (ARDT), LifeStance Health Group (LFST), Celcuity (CELC), and PACS Group (PACS). These companies are all part of the "healthcare" industry. Personalis vs. Its Competitors Heartflow Veracyte Concentra Group Holdings Parent Surgery Partners GRAIL Addus HomeCare Ardent Health LifeStance Health Group Celcuity PACS Group Personalis (NASDAQ:PSNL) and Heartflow (NASDAQ:HTFL) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment. Is PSNL or HTFL more profitable? Heartflow has a net margin of 0.00% compared to Personalis' net margin of -113.70%. Heartflow's return on equity of 0.00% beat Personalis' return on equity.Company Net Margins Return on Equity Return on Assets Personalis-113.70% -47.57% -35.05% Heartflow N/A N/A N/A Which has higher earnings and valuation, PSNL or HTFL? Heartflow has lower revenue, but higher earnings than Personalis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPersonalis$84.61M9.90-$81.28M-$1.28-7.38HeartflowN/AN/AN/AN/AN/A Do analysts prefer PSNL or HTFL? Personalis presently has a consensus target price of $8.25, indicating a potential downside of 12.70%. Heartflow has a consensus target price of $36.60, indicating a potential downside of 8.29%. Given Heartflow's higher possible upside, analysts clearly believe Heartflow is more favorable than Personalis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Personalis 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.71Heartflow 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.67 Do institutionals & insiders have more ownership in PSNL or HTFL? 61.9% of Personalis shares are owned by institutional investors. 3.8% of Personalis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media refer more to PSNL or HTFL? In the previous week, Personalis had 3 more articles in the media than Heartflow. MarketBeat recorded 12 mentions for Personalis and 9 mentions for Heartflow. Personalis' average media sentiment score of 0.56 beat Heartflow's score of 0.56 indicating that Personalis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Personalis 3 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Heartflow 2 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryPersonalis beats Heartflow on 7 of the 11 factors compared between the two stocks. Get Personalis News Delivered to You Automatically Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PSNL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PSNL vs. The Competition Export to ExcelMetricPersonalisMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$838.03M$4.29B$6.17B$10.66BDividend YieldN/A0.88%5.72%4.86%P/E Ratio-7.3811.2429.6328.51Price / Sales9.9020.63578.55129.15Price / CashN/A7.1937.1261.42Price / Book3.294.3312.046.52Net Income-$81.28M-$134.23M$3.32B$276.75M7 Day Performance-8.07%0.05%-0.16%0.20%1 Month Performance54.66%12.93%5.76%1.67%1 Year Performance101.49%71.45%65.69%32.72% Personalis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PSNLPersonalis2.9035 of 5 stars$9.45+5.8%$8.25-12.7%+90.0%$838.03M$84.61M-7.38400News CoverageAnalyst ForecastGap DownHTFLHeartflowN/A$33.22-0.7%$36.60+10.2%N/A$2.79BN/A0.00699News CoverageVCYTVeracyte3.9181 of 5 stars$34.09-2.0%$40.90+20.0%+6.6%$2.74B$445.76M103.31790Analyst ForecastCONConcentra Group Holdings Parent2.5481 of 5 stars$20.17-0.7%$27.75+37.6%-2.3%$2.60B$1.90B16.9511,250SGRYSurgery Partners3.7523 of 5 stars$19.79+0.3%$32.00+61.7%-32.6%$2.53B$3.11B-13.8415,000Positive NewsGRALGRAIL0.6688 of 5 stars$70.44+6.5%$56.67-19.6%+458.9%$2.38B$125.60M-5.371,360Analyst ForecastADUSAddus HomeCare4.733 of 5 stars$112.58-0.3%$137.50+22.1%-6.6%$2.08B$1.15B24.8549,703Positive NewsARDTArdent Health3.3366 of 5 stars$14.10+0.4%$19.33+37.1%-23.4%$2.01B$5.97B7.7924,900LFSTLifeStance Health Group3.5344 of 5 stars$5.11+1.2%$8.50+66.3%-29.7%$1.96B$1.25B-102.2010,218News CoverageCELCCelcuity1.7813 of 5 stars$47.41+2.9%$56.50+19.2%+328.4%$1.95BN/A-13.7440Analyst ForecastPACSPACS Group2.3607 of 5 stars$12.36-2.8%$26.25+112.4%-69.8%$1.94B$3.11B0.0032,433News Coverage Related Companies and Tools Related Companies HTFL Competitors VCYT Competitors CON Competitors SGRY Competitors GRAL Competitors ADUS Competitors ARDT Competitors LFST Competitors CELC Competitors PACS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PSNL) was last updated on 10/23/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Personalis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Personalis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
